Results 61 to 70 of about 14,545 (184)
Moxibustion for diabetic gastroparesis: A protocol for a systematic review and meta-analysis
Moxibustion has been widely used to relieve diabetic gastroparesis. moxibustion has a significant effect in alleviating diabetic gastroparesis. The purpose of this systematic review is to evaluate the effectiveness and safety of moxibustion in treating ...
Jianyu You
core +1 more source
Radical surgery is the cornerstone for achieving curative outcomes in early and locoregionally advanced gastric cancer. However, while radical surgery removes the tumor, it also carries the risk of postoperative complications. Gastroparesis is one of the
Han Xue +4 more
doaj +1 more source
GLP‐1–Based Therapy in Type 1 Diabetes: Balancing Efficacy, Safety, and Patient Selection
ABSTRACT Aims To critically examine the evolving evidence on glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and the dual glucose‐dependent insulinotropic polypeptide (GIP)/GLP‐1 receptor agonist tirzepatide as adjuncts to insulin therapy in type 1 diabetes (T1D), with particular emphasis on their benefit–risk balance in individuals with ...
Thales Rossatto +2 more
wiley +1 more source
Demographic and clinical variables between participants with gastroparesis symptoms and without gastroparesis symptoms.
Turki J. AlHarbi (6111560) +2 more
core +1 more source
Mechanism of action of FoxiangSan in diabetic gastroparesis: Gut microbiota and cAMP/PKA pathway
Diabetic gastroparesis, a common complication of type 2 diabetes (T2DM), presents a significant treatment challenge. FoxiangSan is emerging as a potential therapy.
Jukai Huang +3 more
doaj +1 more source
Human AIMP2 mutations lead to severe neurodevelopmental defects and brain atrophy. Using patient‐derived fibroblasts from two individuals, we show decreased AIMP2 protein levels and overall protein synthesis. In a zebrafish loss‐of‐function model, the lack of AIMP2 leads to an increase in cell death and results in smaller brains.
Patrick Mullen +10 more
wiley +1 more source
Abstract Objectives/Background The introduction of calcitonin gene‐related peptide antagonists has transformed migraine care. Zavegepant, a third‐generation intranasal gepant, offers a nonoral treatment option for acute migraine. Although clinical trials support its efficacy and safety, real‐world data are limited.
Eric Dunn +5 more
wiley +1 more source
Management of Gastric Motility Disorder
Gastric motility disorder or gastroparesis is an objective slowing of gastrointestinal emptying syndrome, in the absence of mechanical obstruction, with cardinal symptoms such as rapid feeling of fullness, fullness sensation after eating, nausea ...
Mustika Dian Permana, Kaka Renaldi
doaj +1 more source
Pharmacologic Treatment for Pediatric Gastroparesis: A Review of the Literature
There have been a number of agents that have been tried for treatment of gastroparesis over the past 3 decades, with varying levels of success.
Bantu, Likeselam +3 more
core +1 more source
Idiopathic Gastroparesis: Lifestyle Modifications Versus Pharmacotherapy [PDF]
Idiopathic gastroparesis is a chronic symptomatic motility disorder of the stomach of unknown cause characterized by delayed gastric emptying in the absence of mechanical obstruction, with the majority of gastroparesis cases being classified as ...
Schieffer, Rebecca K.
core +1 more source

